You may be thinking of Tagrisso: https://www.statnews.com/2020/04/10/astrazeneca-tagrisso-study-ended-overwhelming-benefit/ https://www.statnews.com/2020/04/10/

You may be thinking of Tagrisso: https://www.statnews.com/2020/04/10/astrazeneca-tagrisso-study-ended-overwhelming-benefit/ https://www.statnews.com/2020/04/10/astrazeneca-tagrisso-stu...